Skip to main content

2016 COA Highlights

The New World of Biosimilars
By Meg Barbor, MPH
2016 COA Highlights
June 2016, Vol 6, No 6
The first oncology biosimilar was approved in the United States in 2015, but this category of drugs is still fairly misunderstood, according to Jim M. Koeller, MS, Professor, College of Pharmacy, the University of Texas at Austin. Read More ›